Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Vivanza Biosciences Financial Results

Vivanza Biosciences reported audited standalone annual revenue of ₹112.34 Crore. The Board also noted resignations of its Director and Company Secretary during the meeting.

Key figures
Value₹112.3 Cr
Source

BSE filing, NSE: VIVANZA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Vivanza Biosciences Ltd: key numbers

Share price
₹1.50
Market cap
₹6.00 Cr
Revenue (annual)
₹115.9 Cr
Net profit (annual)
₹0.39 Cr
P/E (TTM)
13.2×Sector 46.1×
Promoter holding
20.02%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Vivanza Biosciences Ltd

All →

Other financial results announcements

All →